title: Target of rapamcyin (TOR)-based therapeutics for cardiomyopathy: insights from zebrafish genetics.
authors.forename: Yonghe
authors.initials: Y
authors.lastname: Ding
authors.forename: Xiaojing
authors.initials: X
authors.lastname: Sun
authors.forename: Margaret
authors.initials: M
authors.lastname: Redfield
authors.forename: Sudhir
authors.initials: S
authors.lastname: Kushwaha
authors.forename: Xiaolei
authors.initials: X
authors.lastname: Xu
mesh_terms: D000818:Animals; D009202:Cardiomyopathies / Q000188:drug therapy* / Q000235:genetics; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D015398:Signal Transduction / Q000187:drug effects; D020123:Sirolimus / Q000494:pharmacology / Q000627:therapeutic use*; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D015027:Zebrafish / Q000235:genetics*
chemical_list: D047428:Protein Kinase Inhibitors; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus